Faster answers. Relieved parents.
The results pediatricians need now with syndromic infectious disease testing from BioFire.
The BioFire® FilmArray® Panels utilize a syndromic approach—simultaneously testing for different pathogens that can cause similar symptoms—to deliver actionable results in about an hour. Create confidence in treatment plans for children and relieve anxious parents with faster answers from the BioFire® FilmArray® Respiratory (RP & RP2) Panels, the BioFire® FilmArray® Meningitis/Encephalitis (ME) Panel, and the BioFire® FilmArray® Gastrointestinal (GI) Panel.
The BioFire ME Panel has been shown to:
- Improve treatment decisions by potential avoidance of unnecessary acyclovir use in HSV-negative pediatric patients.1
- Reduce time-to-result by 10 hours compared to batch method.1
- Reduce hospital stays by avoiding unnecessary hospital admissions by 30%.2
- Double the rate of pathogen detection compared to send-outs.2
- Reduce length of stay by 2 days in children with pediatric central nervous system infections. 3
The BioFire RP Panel has been shown to:
- Improve patient treatment decisions through avoidance of antibiotics in 30% of pediatric patients tested.4
- Provide results to pediatric patients while in the ED 38% more often.5
- Reduce hospital stays by 5 days for febrile infants with a positive result (compared to a negative result).6
- Identify pathogens more often: the BioFire RP Panel produced a 42% positive identification rate in a pediatric population.7
References:
1. Messacar K, et al. (2016) Diagn Microbiol Infect Dis. 86(1):118-20.
2. McNabb KM, et al. 2017. Presented at Carolinas Health Quality Summit.
3. O’Brien MP, et al, (2018) Pediatr Infect Dis J. 37(9):868-871.
4. Sutton C, et al. (2017) ID Week. Poster 1607.
5. Rogers BB, et al. (2015) Arch Pathol Lab Med. 139:636-641.
6. McFall, et al., (2017) Pediatrics. Feb;000992281774066.
7. Subramony A, et al. (2016) J Pediatr. 173:196–201e2.
8. Cybulski R, et al. (2018) CID. 67(11):1688.
9. Beal SG, et al. (2018) J Clin Microbiol. 56(1):01457.
10. Spina A, et al. (2015) Clin Microbiol Infect. 21(8):719-28.
11. Axelrad JE, et al. (2019) J Clin Microbiol. 57(3):e01775-01718.
“If a patient has a set of symptoms but does not have anything identified on the testing, we can potentially send them home from the emergency room or home from the hospital without any further testing and reassurance. If they have a positive test, that means we can get them on the right treatment as soon as possible. ”
-- Tufik Assad, MD, MSCI Critical Care Physician
“We were able to give them a very specific answer, what exactly was going on… So, they were much more comfortable with that decision and plan of going home, expecting it to last a few more weeks and what they can do at home to help support the child, without having that fear that something was being missed the whole time.”
-- Sameer Desai, MD Emergency Medicine Physician
“The patient results were reported while the patients were still in the emergency room. The little girl with Neisseria meningitidis was put on the right antibiotic right away. She was discharged three days later.”
-- Dave Myers, MT, SM(ASCP), MBA Laboratory Manager, Akron Children’s Hospital
The BioFire GI Panel has been shown to:
- Reduce time to result by 84%, compared to traditional culture methods.9
- Detect 25%–36% more possible pathogens compared to traditional testing.8,9,10,11
- Increase targeted, rather than empirical, therapy by 17%.8
- Reduce antibiotics prescribed by 11%.11
- Reduce downstream procedures, such as X-rays, ultrasounds, CT scans, and endoscopies.9,11
